Industry insiders projected that 2023 would be a year of reckoning for autism treatment providers.  The reckoning is here. Major platform companies have made significant stumbles, and workforce challenges still plague the industry. All the while, payers continue to hold out on raising reimbursement rates for most autism therapies. Instead, payers eye value-based care arrangements. […]